Qiu, Hong <br/><br/>
Inhibiting Notch1 enhances immunotherapy efficacy in melanoma by preventing Notch1 dependent immune suppressive properties.  [electronic resource] 

 -  Cancer letters  10 2018 
 - 144-151 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2018.07.024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cell Line, Tumor<br/>Cytokines--genetics<br/>Female<br/>Humans<br/>Immunotherapy--methods<br/>Ipilimumab--administration & dosage<br/>Melanoma, Experimental--genetics<br/>Mice, Inbred C57BL<br/>Myeloid-Derived Suppressor Cells--immunology<br/>Nivolumab--administration & dosage<br/>RNA Interference<br/>Receptor, Notch1--genetics<br/>T-Lymphocytes, Regulatory--immunology<br/>Treatment Outcome<br/>Tumor Burden--drug effects<br/>Tumor Microenvironment--drug effects